CAN (BC): Grower signs agreement with breeder

Zenabis Global has entered into an agreement with Tantalus Labs, pursuant to which Zenabis will grow and harvest cannabis plants from clones provided by Tantalus Labs.

"The plants will be grown and harvested at Zenabis Langley," the team with the company explains. "Tantalus Labs will be responsible for all drying, trimming and packaging at its own licensed facilities. The initial term of the Cultivation Agreement will be two years with the option to renew thereafter for successive two-year terms by mutual written agreement of the parties. In 2020 and 2021, Zenabis expects to grow and supply quantities of cannabis plants that will be sufficient for Tantalus Labs to produce thousands of kilograms of dried cannabis.

“Tantalus is excited to leverage the proven QA systems and elite agricultural insight of Zenabis at their Langley facility. This relationship will allow Tantalus to deliver our sungrown quality promise to an expanding audience in Canada, while collaborating with some of the brightest agricultural minds in this new Canadian cannabis industry. Our team is motivated to evolve our quality standards with Zenabis for years to come.” said Dan Sutton, Chief Executive Officer, Tantalus Labs.

Andrew Grieve, Chief Executive Officer of Zenabis, stated, “Given Tantalus Labs’ meticulous approach to the design and construction of its own facility, we are pleased that it has selected Zenabis as a cultivation partner. We share Tantalus Labs’ commitment to continuously push growing practices and standards onward and upward for the efficient production of high-quality, sungrown cannabis. To that end, we are excited to enter into this innovative agreement that leverages extensive cultivation experience of the Zenabis team and Zenabis Langley’s significant design capacity.”

For more information:

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.